Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Submitted by
admin
on October 28, 2016 - 10:07am
Source:
Stat
News Tags:
PCSK9 inhibitors
Amgen
Regeneron
Sanofi
Repatha
Praluent
statins
Headline:
These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating
Do Not Allow Advertisers to Use My Personal information
